Ketamine Therapy in Texas

Ketamine therapy in Texas is governed by a combination of federal and state regulations. At the federal level, ketamine is classified as a Schedule III controlled substance under the Controlled Substances Act, meaning that any clinic or provider administering ketamine must be registered with the Drug Enforcement Administration (DEA) and adhere to strict protocols for prescribing, dispensing, and record-keeping. At the state level, the Texas State Board of Medical Examiners (TSBME), now operating as the Texas Medical Board (TMB), oversees physician licensure and the standard of care for all medical treatments, including ketamine infusion therapy. Physicians who administer or supervise ketamine treatments must hold a valid Texas medical license and maintain DEA registration for handling Schedule III substances.

Ketamine infusion clinics in Texas are generally required to operate within a licensed medical facility or physician's office setting, with a qualified physician present or immediately available during infusion procedures. The TMB expects providers to conduct thorough patient evaluations prior to initiating treatment, obtain informed consent, and maintain comprehensive medical records. While Texas does not currently have a specific standalone statute dedicated exclusively to ketamine therapy, providers are expected to comply with all applicable rules governing the practice of medicine, including those related to off-label drug use, as ketamine is FDA-approved only as an anesthetic agent and is used off-label for conditions such as treatment-resistant depression, PTSD, and chronic pain.

Patients and providers should also be aware of regulations surrounding the newer FDA-approved nasal spray esketamine (Spravato), which is a ketamine-derived medication approved specifically for treatment-resistant depression and major depressive disorder with suicidal ideation. Spravato carries a Risk Evaluation and Mitigation Strategy (REMS) program requirement, meaning it can only be dispensed and administered in certified healthcare settings where patients are monitored for at least two hours after each dose. This distinction is important, as Spravato may be covered by insurance in some cases, while traditional IV ketamine infusions are typically considered off-label and are not covered by most insurance plans in Texas.

Individuals seeking ketamine therapy in Texas are encouraged to verify that their chosen provider meets all applicable licensing and regulatory requirements. Key considerations when evaluating a clinic include:

• Confirmation that the administering physician holds an active Texas Medical Board license
• Verification of the provider's DEA registration for Schedule III controlled substances
• Availability of appropriate emergency equipment and protocols on-site
• A thorough intake and evaluation process prior to beginning treatment
• Clear, written informed consent documentation and transparent pricing practices